| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| trajenta | 1.16 | 0.9 | 2079 | 3 | 8 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| trajenta | 0.32 | 0.9 | 4869 | 12 |
| tradjenta | 0.52 | 0.5 | 5265 | 43 |
| trajenta 5 mg | 1.94 | 0.2 | 7001 | 6 |
| tradjenta medication | 1.78 | 0.7 | 7057 | 63 |
| trajenta duo | 1.31 | 0.2 | 7735 | 1 |
| trajentamet | 0.32 | 0.6 | 2196 | 82 |
| trajenta tablet | 1.23 | 0.8 | 6125 | 63 |
| tradjenta dosage | 0.78 | 0.4 | 9782 | 100 |
| tradjenta class | 0.72 | 0.3 | 9523 | 67 |
| trajenta spc | 0.54 | 0.6 | 1220 | 30 |
| trajenta duo 2.5/500 | 1.98 | 0.7 | 9635 | 4 |
| tradjenta generic | 0.28 | 0.8 | 5940 | 54 |
| trajenta mp | 0.92 | 0.4 | 4503 | 98 |
| tradjenta coupon | 0.02 | 0.7 | 8388 | 72 |
| trajenta fk | 1.68 | 0.6 | 3553 | 16 |
| trajenta fass | 1.64 | 0.2 | 4755 | 14 |
| tradjenta cost | 0.29 | 0.8 | 291 | 54 |
| tradjenta side effects | 1.62 | 0.9 | 9583 | 63 |
| trajenta chpl | 1.33 | 0.4 | 1614 | 96 |
| trajenta 5 mg tab | 0.8 | 1 | 5965 | 7 |
| trajenta compendium | 0.53 | 0.4 | 7423 | 66 |
| trajenta 5mg tablets | 1.15 | 0.4 | 5419 | 85 |
| trajenta duo 5/1000 | 1.48 | 0.4 | 8673 | 15 |
| trajenta principio attivo | 1.79 | 0.7 | 2280 | 80 |
| trajenta ficha tecnica | 0.59 | 0.5 | 3035 | 9 |
Trajenta is used to treat type-2 diabetes with the following antidiabetes medicines when blood sugar levels are not already adequately controlled by diet, exercise and these antidiabetes medicines taken alone: 1 metformin; 2 metformin and a sulphonylurea; 3 insulin, either on its own or together with metformin.
What is Tradjenta used for?Tradjenta Generic Name: linagliptin Linagliptin is used with a proper diet and exerciseprogram and possibly with other medicationsto control high blood sugar. It is used by people with type 2 diabetes.
How many mg of trajenta are there?It is available as tablets (5 mg). What is Trajenta used for? Trajenta is used to treat type-2 diabetes with the following antidiabetes medicines when blood sugar levels are not already adequately controlled by diet, exercise and these antidiabetes medicines taken alone: insulin, either on its own or together with metformin.
Do the benefits of trajenta outweigh the risks?The Committee therefore concluded that the benefits of Trajenta outweigh its risks and recommended that it be granted marketing authorisation. The European Commission granted a marketing authorisation valid throughout the European Union for Trajenta on 24 August 2011.
